Joyfes Healthcare Services Ltd 09208099 true 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Other human health activities Digita Accounts Production Advanced 6.30.9574.0 true Mrs Omolola Odunayo Olubayo true 09208099 2023-04-01 2024-03-31 09208099 2024-03-31 09208099 bus:OrdinaryShareClass1 2024-03-31 09208099 core:RetainedEarningsAccumulatedLosses 2024-03-31 09208099 core:ShareCapital 2024-03-31 09208099 core:CurrentFinancialInstruments 2024-03-31 09208099 core:Non-currentFinancialInstruments 2024-03-31 09208099 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 09208099 bus:FRS102 2023-04-01 2024-03-31 09208099 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 09208099 bus:FullAccounts 2023-04-01 2024-03-31 09208099 bus:RegisteredOffice 2023-04-01 2024-03-31 09208099 bus:CompanySecretaryDirector1 2023-04-01 2024-03-31 09208099 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 09208099 bus:EntityNoLongerTradingButTradedInPast 2023-04-01 2024-03-31 09208099 bus:Consolidated 2023-04-01 2024-03-31 09208099 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09208099 core:OfficeEquipment 2023-04-01 2024-03-31 09208099 countries:England 2023-04-01 2024-03-31 09208099 2023-03-31 09208099 bus:OrdinaryShareClass1 2023-03-31 09208099 core:RetainedEarningsAccumulatedLosses 2023-03-31 09208099 core:ShareCapital 2023-03-31 09208099 core:CurrentFinancialInstruments 2023-03-31 09208099 core:Non-currentFinancialInstruments 2023-03-31 09208099 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09208099

Joyfes Healthcare Services Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

Joyfes Healthcare Services Ltd

Profit and Loss Account for the Year Ended 31 March 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Joyfes Healthcare Services Ltd

(Registration number: 09208099)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Current assets

 

Debtors

3

3,769

3,769

Cash at bank and in hand

 

12

12

 

3,781

3,781

Creditors: Amounts falling due after more than one year

(16,850)

(16,850)

Net liabilities

 

(13,069)

(13,069)

Capital and reserves

 

Called up share capital

5

1

1

Retained earnings

(13,070)

(13,070)

Shareholders' deficit

 

(13,069)

(13,069)

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 18 October 2024
 

.........................................
Mrs Omolola Odunayo Olubayo
Company secretary and director

 

Joyfes Healthcare Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
131 Serpentine Court
Bletchley
Milton Keynes
MK2 3QN
United Kingdom

These financial statements were authorised for issue by the director on 18 October 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Depreciation

Asset class

Depreciation method and rate

Office equipment

33% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Joyfes Healthcare Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Debtors

4

Cash and cash equivalents

2024
£

2023
£

Cash at bank

12

12

5

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

1

1

1

1

       

6

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

6,411

6,411

Other borrowings

10,439

10,439

16,850

16,850